Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study

PURPOSE: To evaluate the effectiveness, safety, and treatment patterns of ranibizumab 0.5 mg in prior ranibizumab-treated patients with neovascular age-related macular degeneration (nAMD) enrolled in the LUMINOUS(™) study. PATIENTS AND METHODS: LUMINOUS, a 5-year, prospective, multicenter, observati...

Descripción completa

Detalles Bibliográficos
Autores principales: Holz, Frank G., Minnella, Angelo M., Tuli, Raman, Yoganathan, Pradeepa, Parikh, Soumil, Hamilton, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773197/
https://www.ncbi.nlm.nih.gov/pubmed/33378369
http://dx.doi.org/10.1371/journal.pone.0244183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773197/
https://www.ncbi.nlm.nih.gov/pubmed/33378369
http://dx.doi.org/10.1371/journal.pone.0244183

Ejemplares similares